Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
RENE.L Share News (RENE)
RENE Share
Price
RENE Share
News
RENE Share
Chat
RENE Share
Trades
RENE
Live RNS
RENE Share
Charts
RENE Broker
Ratings
RENE Directors
Deals
RENE Financial
Diary
RENE
Fundamentals
RENE Short
Positions
RENE
Media
RENE Company
Research
RENE Company
Timeline
- There is currently no data for RENE
ReNeuron Expects To Enroll First Patient For Stroke Study Shortly
LONDON (Alliance News) - ReNeuron Group PLC said Wednesday it expects to enroll the first patient in its stroke disability study "shortly".
The company said that the first clinical site has been initiated in the US Phase IIb study, with its CTX cell therapy as a candidate for stroke disability.
"The primary end-point of the study is the proportion of patients in the treated and placebo arms showing a clinically important improvement on the modified Rankin Scale (mRS) at six months post-treatment compared with baseline," the company said.
The mRS is a global measure of disability which depends on a person's dependence on others.
The company expects data from the study in early 2020, "slightly later than planned".
ReNeuron shares were trading up 1.9% at 84.60 pence each on Wednesday.
Latest RENE News
- IN BRIEF: ReNeuron administrators in talks with potential investors
17 May 2024 - TRADING UPDATES: PetroTal buys Peru's Block 131 for USD5.0 million
17 May 2024 - ReNeuron CFO steps down to pursue other opportunities
17 Apr 2024 - TRADING UPDATES: ReNeuron appoints administrators as rescue talks fail
20 Mar 2024 - TRADING UPDATES: ReNeuron warns; Gama Aviation pledges cash return
5 Feb 2024 - ReNeuron interim loss narrows on lower costs; eyes partnerships
8 Nov 2023 - ReNeuron reaches exosome research milestone
4 Sep 2023 - IN BRIEF: ReNeuron makes progress on exosome delivery platform
4 Sep 2023
Related News
IN BRIEF: ReNeuron administrators in talks with potential investors
ReNeuron Group PLC - Brigdend, Wales-based stem cell and exosomes technology company - Says Mark Smith and Stephen Cork of Cork Gully LLP, joint admin...
TRADING UPDATES: PetroTal buys Peru's Block 131 for USD5.0 million
(Alliance News) - The following is a round-up of updates by London-listed companies, issued last week Wednesday and not separately reported by Allianc...
ReNeuron CFO steps down to pursue other opportunities
(Alliance News) - ReNeuron Group PLC on Wednesday announced Chief Financial Officer John Hawkins will be stepping down from his role on May 7.
RENE.L News
IN BRIEF: ReNeuron administrators in talks with potential investors
ReNeuron Group PLC - Brigdend, Wales-based stem cell and exosomes technology company - Says Mark Smith and Stephen Cork of Cork Gully LLP, joint admin...
TRADING UPDATES: PetroTal buys Peru's Block 131 for USD5.0 million
(Alliance News) - The following is a round-up of updates by London-listed companies, issued last week Wednesday and not separately reported by Allianc...
ReNeuron CFO steps down to pursue other opportunities
(Alliance News) - ReNeuron Group PLC on Wednesday announced Chief Financial Officer John Hawkins will be stepping down from his role on May 7.
TRADING UPDATES: ReNeuron appoints administrators as rescue talks fail
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
TRADING UPDATES: ReNeuron warns; Gama Aviation pledges cash return
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
ReNeuron interim loss narrows on lower costs; eyes partnerships
(Alliance News) - ReNeuron Group PLC on Wednesday reported a slight narrowing in interim loss as costs decreased, as it highlighted its focus on its e...
ReNeuron reaches exosome research milestone
(Sharecast News) - UK-based biotechnology company ReNeuron Group, which specialises in stem cell-derived exosome technologies, announced significant a...
IN BRIEF: ReNeuron makes progress on exosome delivery platform
ReNeuron Group PLC - Brigend, Wales-based stem cell and exosomes technology company - Generates in vivo data to exemplify cellular and tissue targetin...
Follow the stocks
